teriflunomide Articles
Sanofi-Aventis’ oral drug teriflunomide reduces relapses in multiple sclerosis patients by 31%
18 October 2010
Novartis gets Russian approval for oral MS drug Gilenya (fimgolimid)
13 September 2010
Genzyme snubs Sanofi-Aventis’ $18.5 billion offer; French drugmaker reports good data for MS drug teriflunomide
31 August 2010
Showing 1-4 of 4 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
